Multiplex Molecular in vitro Diagnostics

IntelliPlex™  SARS-CoV-2

The PLEXBIO™ IntelliPlex™ SARS-CoV-2 Detection Platform

The IntelliPlex™ SARS-CoV-2 detection platform provides an automated solution to address the urgent need for the high-volume testing during the Coronavirus disease 2019 (COVID-19) pandemic.

The IntelliPlex™ SARS-CoV-2 kit is a molecular in vitro diagnostic test that aids in the detection and diagnosis COVID-19 and is based on widely used nucleic acid amplification technology.

The IntelliPlex™ SARS-CoV-2 Detection Kit detects the presence of N, RdRp, and E genes of SARS-CoV-2 in RNA extracted from respiratory specimen.

Features include:
• Simultaneously detect 3 genes (E, N, and RdRp) in SARS-CoV-2 to minimize the probability of false negative test results due to the fast-evolving pace of this virus
• Process up to 564 samples in 9 hours. (96 rxns/kit)
• High sensitivity (140 copies/mL)


2-3 Week Installation
FDA EUA, CE-IVD 

EUA USER MANUAL
FACT SHEET FOR HEALTHCARE PROVIDERS
FACT SHEET FOR PATIENTS
SAFETY DATA SHEET

Request an Installation


Your Webinar Request Has Been Sent!

Your message has been sent successfully, We will respond within 24 hours. You may also contact us directly at [email protected]

3729 Main Street
College Park, GA, 30337

Ailm Medical LLC DBA NewNorm Platform
"Women Owned*
Website evolving in Real Time. Please excuse the construction.